The Role of Ghrelin in Cancer Cachexia
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2018
Price : $35 *
At a glance
- Drugs Anamorelin (Primary)
- Indications Cachexia; Non-small cell lung cancer
- Focus Pharmacodynamics
- 09 Aug 2016 Status changed from active, no longer recruiting to discontinued due to poor recruitment.
- 02 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov .
- 29 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2016, as per ClinicalTrials.gov .